Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus
| Autor: | Pedro J Martı́nez, M. Teresa Castells, M. Luisa Laorden, M. Delia MartÍnez, M. Victoria Milanés |
|---|---|
| Rok vydání: | 2000 |
| Předmět: |
Agonist
Male Narcotics medicine.medical_specialty medicine.drug_class Narcotic Antagonists Receptors Opioid mu (+)-Naloxone c-Fos κ-opioid receptor Supraoptic nucleus Methoxyhydroxyphenylglycol Rats Sprague-Dawley Norepinephrine Endocrinology Internal medicine medicine Animals biology Morphine Chemistry Naloxone Receptors Opioid kappa 3 4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide (trans)-Isomer Methane sulfonate Receptor antagonist Naltrexone Rats Hypothalamus biology.protein Suprachiasmatic Nucleus Proto-Oncogene Proteins c-fos Supraoptic Nucleus Paraventricular Hypothalamic Nucleus |
| Zdroj: | Endocrinology. 141(4) |
| ISSN: | 0013-7227 |
| Popis: | Administration of the preferential mu-opioid receptor agonist, morphine, and selective K-opioid receptor agonists elicits activation of the hypothalamus-pituitary-adrenocortical axis, although the site or the molecular mechanisms for these effects have not been determined. The expression ofFos, the protein product of the c-fos protooncogene, has been widely used as an anatomical marker of monitoring neuronal activity. In the present study we evaluated 1) the effects of the mu-opioid receptor agonist, morphine, and those of the selective K-opioid receptor agonist, trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl-]benzeneacet amide methane sulfonate (U-50,488H), administration on the expression of Fos in hypothalamic nuclei; and 2) the possible modification of the activity of noradrenergic neurons known to send afferent projections to the paraventricular nucleus (PVN), the site of CRF neurons involved in initiating ACTH secretion. Using immunohistochemical staining of Fos, the present results indicate that acute treatment with either morphine or U-50,488H induces marked Fos immunoreactivity within the hypothalamus, including the medial parvicellular PVN and supraoptic and suprachiasmatic nuclei. Pretreatment with naloxone attenuated the effect of morphine, whereas nor-binaltorphimine, a selective kappa-opioid receptor antagonist, abolished the effect of U-50,488H on Fos induction. Correspondingly, morphine and U-50,488H injection increased the production of the cerebral noradrenaline metabolite 3-methoxy-4-hydroxyphenylethylene glycol as well as noradrenaline turnover in the PVN. These effects were antagonized by naloxone and nor-bin-altorphimine, respectively. All of these findings are discussed in terms of specific events that couple opioid-induced activation of the hypothalamus-pituitary-adrenocortical axis and noradrenergic activity with changes in gene expression in selective hypothalamic nuclei. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|